The BMJ study was done to find out gender-related factors for pre-diabetes. The study found that males with active physical activity and females with lower waist circumference are good for reversion from diabetes condition to normal condition. Following factors turn the male person from pre-diabetes to diabetes
Following factors turn a female from prediabetes to diabetes
Diasend in collaboration with Abbott introduced Freestyle Libre wireless glucose monitoring system. Patients can import information into Diasend with LibreLink App. The patient needs to connect Android smartphone equipped with LibreLink App and a connected FreeStyle Libre sensor. Freestyle Libre is a specially devised wireless sensor, of the size of a 20 cent coin, to check blood glucose levels continuously without taking blood from the body. The sensor can read glucose levels by inserting a tiny pin into the arm. The sensor is water resistant and with adhesive backing. It gives reading in less than a second. The patient can view, upload and store combined information from Diasend compatible devices such as
A research study results show that children's cholesterol levels significantly higher in the families having a strong history of cardiovascular disease (CVD) and/or with type ii diabetes (T2D) condition. Those children have unfavorable levels of cardiometabolic markers and are at high risk of heart attacks and strokes in adulthood. The unfavorable markers are
The study findings were published in Diabetologia.
Public healthcare group Singhealth (Singapore) signed MOU with Medtronic International Limited (Ireland) on 31st May 2016. They are cooperating in areas of
Before signing of MOU, the global medical technology company, Medtronic announced that they are opening Asia Pacific regional office in Mapletree Business City in Pasir Panjang. Medtronic announced that they are going to manufacture next-generation MRI-safe pacemakers, cardiac monitoring devices and other products from Singapore. Eating unhealthy foods with high fat, salt and sugar combined with no physical activity causing diabetes in the lives of people.
FDA has approved Jentadueto XR tablets for the treatment of type 2 diabetes (T2D) in adult patients. JENTADUETO XR is an extended-release therapy table which gives the convenience of a combination pill (2.5/5 mg of linagliptin + 1000 mg of metformin) taken once a day to keep blood sugar levels under control. The tablet will improve glycemic levels. Linagliptin works by increasing hormones. The increased hormones stimulate the pancreas. When stimulated, the pancreas makes more insulin. Linagliptin also acts on the liver to produce less glucose. The company says JENTADUETO XR should not be used for
The package warns about the risk of lactic acidosis. The patient should seek medical help if he experiences following symptoms.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.